Pharmas earning big PBS bucks

Johnson & Johnson Innovative Medicine (Janssen) and Novartis remained the biggest PBS players during the financial year ending 2024, each earning $1 billion for a third consecutive year, according to the latest PBS Expenditure and Prescriptions Report.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here